XML 18 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED CONDENSED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Restricted Stock
Options and Restricted Stock
Common Stock
Common Stock
Options and Restricted Stock
Additional Paid-in Capital
Additional Paid-in Capital
Restricted Stock
Additional Paid-in Capital
Options and Restricted Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Treasury Stock
Beginning Balance (in shares) at Dec. 31, 2019       95,649             1,451
Beginning Balance at Dec. 31, 2019 $ 767,353     $ 956   $ 323,600     $ 489,382 $ (22,422) $ (24,163)
Beginning Balance (ASU 2016-13 (Topic 326)) at Dec. 31, 2019 (289)               (289)    
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Share-based compensation 1,861         1,861          
Acquisition of treasury stock (in shares)                     (1,167)
Acquisition of treasury stock (21,938)                   $ (21,938)
Exercise of stock options (in shares)                     20
Exercise of stock options 130         (203)         $ 333
Compensatory awards released from restriction 0         (18,129)         $ 18,129
Compensatory awards released from restriction (in shares)                     1,055
Stock dividends 0         4     (34)   $ 30
Stock dividends (in shares)       0             2
Cash dividends (949)               (949)    
Equity adjustment from foreign currency translation (14,936)                 (14,936)  
Change in fair value of derivative instruments, net of tax (159)                 (159)  
Net income 28,894               28,894    
Ending Balance (in shares) at Mar. 31, 2020       95,649             1,541
Ending Balance at Mar. 31, 2020 759,967     $ 956   307,133     517,004 (37,517) $ (27,609)
Beginning Balance (in shares) at Dec. 31, 2020       95,649             1,446
Beginning Balance at Dec. 31, 2020 675,644     $ 956   346,945     360,228 (6,546) $ (25,939)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock issued during period, shares, acquisitions (in shares)       89,776 188            
Stock issued during period, value, acquisitions 2,650,201   $ 0 $ 898 $ 2 2,649,303   $ (2)      
Share-based compensation 4,609 $ 33,051       4,609 $ 33,051        
Acquisition of treasury stock (in shares)                     (400)
Acquisition of treasury stock (12,501)                   $ (12,501)
Exercise of stock options (in shares)                     40
Exercise of stock options 257         (452)         $ 709
Compensatory awards released from restriction 0         (16,565)         $ 16,565
Compensatory awards released from restriction (in shares)                     864
Stock dividends 0         13     (36)   $ 23
Stock dividends (in shares)                     1
Cash dividends (3)               (3)    
Equity adjustment from foreign currency translation (16,243)                 (16,243)  
Change in fair value of derivative instruments, net of tax 5,343                 5,343  
Net income 272,461               272,461    
Ending Balance (in shares) at Mar. 31, 2021       185,613             941
Ending Balance at Mar. 31, 2021 $ 3,612,819     $ 1,856   $ 3,016,902     $ 632,650 $ (17,446) $ (21,143)